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Pregancy in the human presents an "immunological paradox," because of the unexpected
willingness of mothers to accept genetically disparate tissues. The fact that the fetus can develop
unharmed for nine months shows that protective mechanisms must exist to permit its survival.
The conditions that permit the genetically dissimilar human fetus to evade rejection by its
mother’s immune system have been the subject of intense interest for several decades. As the
placental cells, which are in contact with maternal blood or tissue, are devoid of HLA class II
antigens, interest has focused on the expression of HLA class molecules. Recent developments
in the constitutive, transcriptional, and translational expression of HLA class molecules on
anatomically and morphologically different subpopulations of trophoblast cells will form the
basis of this short review.
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INTRODUCTION
The human major histocompatibility complex region
(MHC) spans about 4000 kb in the distal region of the
short arm of chromosome 6, containing class I, II, and
III subregions. The class I subregion is larger than the
two others and encodes cell-surface glycoproteins of
m.w. 40 to 45 kD that associate noncovalently with
the 12-kD/32-microglobulin (/32-m) light chain. These
include the three polymorphic molecules HLA-A,-B,
and-C, which are ubiquitously expressed and are able
to give rise to immune reactions by presenting
peptides from intracellularly degraded proteins on the
cell surface (Le Bouteiller, 1994). They allow dis-
crimination of "self,’ from "nonself,’ and serve as
restriction elements for virus-specific and allo-spe-
cifi T lymphocytes. In addition, they affect the
activities of natural killer (NK) cells.
Three additional class I genes commonly referred
as nonclassical or class Ib genes, all highly homo-
logous to the other class I genes and all of which
associate with /32-m, complete this gene family
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(Geraghty et al., 1987, 1990; Koller et al., 1988; Le
Bouteiller, 1994). In humans, each of the class Ib
genes appears to exhibit a distinct pattern of
expression in developing and adult tissues. HLA-E
transcripts are distributed widely in adult tissues and
have also been found in the placenta and fetal liver
(Wei and Orr, 1990; Houlihan et al., 1992). HLA-E
can be regarded as ubiquitous, like the classical HLA
class I molecules. The HLA-E gene is thought to
represent an ancient gene as there are data suggesting
that the polymorphism at the HLA-E locus may have
existed before the appearance of most HLA-A, -B,
and-C polymorphism (Geraghty et al., 1992).
Furthermore, this locus is conserved between
macaques and humans (Boyson et al., 1995). Such a
maintenance through evolution is likely to reflect a
significant and important function; however, this
function is still unknown. The group headed by P. Le
Bouteiller (Boucrout et al., 1993) suggests that HLA-
E may have functional importance as a housekeeping
gene, as it is expressed as the only HLA class I
molecule in the trophoblast-derived cell line JAR.
In the adult, the presence of HLA-F has been
shown in skin, resting T cells, and B cells (Geraghthy
et al., 1990), whereas in development, its expression
was reported in fetal l[ver (Houlihan et al., 1992) and
in low levels in placenta and extraplacental tissues
(Wei and Orr, 1990).
HLA-G is the most interesting nonclassical HLA
class I molecule, because of its exceptional high
expression at the maternal-fetal interface, suggesting
that HLA-G plays a critical role in human pregnancy.
In contrast to classical HLA class I genes, the primary
HLA-G transcript is alternately spliced, giving rise to
at least five distinct mRNAs, named HLA-G1 to
HLA-G5 (Ishitani and Geraghty, 1992; Fujii et al.,
1994; Kirszenbaum et al., 1994; Moreau et al., 1995).
These mRNAs transcribe membrane-bound and
soluble forms of HLA-G antigens (for a recent
review, see Carosella et al., 1996). The relative levels
of the alternate mRNAs are affected by the cell type
and the developmental stage of the expressing tissue
(Ishitani and Geraghty, 1992). However, because of
the lack of antibodies recognizing the different
isoforms, it is not clear to what extent these
alternately spliced mRNAs are translated to protein.
Most of the reports of HLA-G expression refer to
HLA-G1, which possesses a full-length mRNA,
giving rise to a protein containing all domains. The
HLA-G1 protein product has 86% sequence identity
with the class I consensus sequence (Parham et al.,
1988). HLA-G was shown to be synthesized as five
37- to 39-kD isoforms, one of which is secreted
(Kovats et al., 1990).
Messenger RNA for HLA-G has been detected in
several embryonic and adult tissues, including adult
and fetal thymus (Wei and Orr, 1990), fetal liver and
eye (Shukla et al., 1990; Houlihan et al., 1992), adult
spleen (Onno et al., 1994), keratinocytes (Ulbrecht et
al., 1994), but the protein was reported to be restricted
to several populations of trophoectodermal-derived
trophoblast and choriocarcinoma cells (Kovats et al.,
1990; Chumbley et al., 1994a). However, HLA-G
protein was also found recently on embryoblast-
derived amnion epithelial cells and in the amnionic
fluid (Hammer et al., 1996) and in human mono-
nuclear phagocytes (Yang et al., 1996).
THE MATERNAL-FETAL INTERFACE
The maternal-fetal interface extends over almost the
entire surface of the fetal membranes and the
placenta. During the course of pregnancy, the fetus
itself does not come into direct contact with maternal
tissue; it is the trophoblast, which constitutes the
effective intrauterine tissue allograft and forms the
interface between the maternal and fetal compart-
ments (Benirschke and Kaufmann, 1995). Within the
membranes, extravillous cytotrophoblast cells of the
chorion laeve are in close contact with maternal cells
of the decidua capsularis. As pregnancy goes on, they
are additionally in contact with maternal cells of the
decidua parientalis. Within the placenta, the syncytio-
trophoblast, which overlays a layer of villous cyto-
trophoblast cells, forms the outer surface of the
chorionic villi, directly facing the maternal blood that
perfuses the intervillous space.
The basal plate is an intimate contact zone of
maternal and fetal tissues. The early precursor of theHLA-EXPRESSION ON TROPHOBLAST CELLS 199
basal plate is the trophoblastic shell. During implanta-
tion, it consists merely of syncytiotrophoblast. With
the formation of chorionic villi, increasing amounts of
cytotrophoblast cells come into contact with the
maternal decidua basalis. These extravillous cyto-
trophoblast cells proliferate within the cell columns of
anchoring villi, and subsequently leave the prolifera-
tion zones, and deeply invade maternal tissue and
even maternal blood vessels. By considering mor-
phology and anatomical location, different subsets of
invasive extravillous cytotropblast cells may be
distinguished: Interstitial trophoblast cells are inter-
posed between maternal cells of the decidua basalis
outside of the uteroplacental vessels. Intramural
trophoblast cells are incorporated into the arterial
walls, and intraluminal trophoblast cells are located
directly within the lumen of the uteroplacental
arteries. All of these extravillous cytotrophoblast cells
are in intimate contact with a variety of maternal
tissues, namely, uterine glandular cells, stromal cells,
endothelial cells, and maternal leukocytes, and with
maternal blood. The maternal leukocytes present in
human decidua during the early weeks of pregnancy
are composed of CD56 NK-like cells (--80%), CD3
T cells (--10%), and CD14 macrophages (--10%)
(King et al., 1989; Bulmer et al. 1991). In the basal
plate, the contact between fetal and maternal cells is
most intimate during the invasive phase at the onset of
pregnancy; later the two cell populations are
separated mostly by fibrinoid.
HLA CLASS I EXPRESSION IN THE
PLACENTA
Anatomically and morphologically distinct subpopu-
lations of trophoblast cells contain different levels of
HLA class I mRNA and express the protein antigen
differently from one another. These antigens are
either totally inhibited or are carefully selected from
among the many members of the class I multigene
family. Furthermore, within a given trophoblast cell
population, the expression is dependent on the stage
of gestation; generally, first-trimester trophoblast cells
transcribe more HLA class I mRNA (Wei and Orr,
1990) and contain more HLA class I protein (Kovats
et al., 1990) than term trophoblast cells. The differ-
entiated expression of HLA class I molecules in
trophoblast cells requires several controlling mecha-
nisms both on the transcriptional as well as on the
translational level; for recent reviews referring to this
topic, see Le Bouteiller et al. (1996) and Hunt and
Hutter (1996). On the basis of the more recent data,
the constitutive, transcriptional, and translational
expression of classical and nonclassical HLA class I
molecules in the different trophoblast-cell subpopula-
tions that constitute the materno-fetal interface during
human pregnancy is as follows.
Most syncytiotrophoblast lacks HLA class I mRNA
and, if these molecules are transcribed at all, the
transcription is very low. Low amounts of HLA class
I mRNA were shown by in situ hybridization on first-
trimester syncytiotrophoblast (Hunt et al., 1988),
which were identified later to be HLA-G (Yelavarthi
et al., 1991). In syncytiotrophoblast of term placenta,
the presence of HLA-A and -B/-C mRNA has been
described (Guillaudeux et al., 1995). However, the
experiments for the detection of the mRNA for HLA-
A, -B/-C were carried out on an in vitro differentiated
syncytiotrophoblast derived from villous cytotropho-
blast cells and, as the authors state, the possibility that
the HLA transcripts derived from cell contamination
cannot be excluded. It is not clear in general whether
HLA class I mRNA detected in syncytiotrophoblast is
truly synthesized or the message is possibly donated
by merging cytotrophoblast cells (Hunt et al., 1990).
The in vivo syncytiotrophoblast is reported to lack the
expression ofHLA class I protein; and in fact, we and
others have not been able to find any HLA class I
antigen with the antibodies available so far. However,
preliminary results from Ishitani et al. (1996) carried
out with a new antibody show a staining for soluble
HLA-G. As the transcription for HLA class I
molecules in syncytiotrophoblast is very low, the
source of this antigen is not clear and further
experiments have to be done to clarify the situation.
Villous cytotrophoblast cells are known to tran-
scribe class I molecules, but the transcription seems to
be not homogenous. In situ hybridization with first-
trimester specimens showed that in many villi, the200 H. HUTTER et al.
villous cytotrophoblast cells did not contain HLA-G
mRNA (Yelavarthi et al., 1991). The nonclassical
HLA class I molecules HLA-E and -F were not found
in villous cytotrophoblast cells of first-trimester
specimens by in situ hybridization (Yelavarthi et al.,
1991; Chumbley et al., 1993); the only HLA-E-
positive cells were identified morphologically as
lymphocytes. However, two transcripts ofHLA-E and
three isoforms of HLA-G were found by Northern
blotting and Reverse Transcription-Polymerase Chain
Reaction (RT-PCR), respectively, in purified term
villous cytotrophoblast (Guillaudeux et al., 1995).
Among the classical HLA class I genes, mRNA
specific for HLA-C in first-trimester villous cyto-
trophoblast cells and HLA-A and possibly also -B in
term villous cytotrophoblast cells could be demon-
strated by RT-PCR and Northern blotting, respec-
tively (King et al., 1996a). The expression of HLA-B,
however, is doubtful because the probe used by
Guillaudeux et al. (1995) is known to cross hybridize
with HLA-C even under stringent hybridization
conditions. Therefore, it is possible that, in fact, HLA-
C was detected. Immunohistochemical staining with
different antibodies against HLA class I heavy chains
or heavy chains associated with/32-m failed to react
with villous cytotrophoblast cells. Recently, Rodri-
guez et al. (1996) reported that classical HLA class I
heavy chains remain unfolded in the endoplasmatic
reticulum of villous cytotrophoblast cells through the
association with calnexin due to a posttranslational
defect involving the peptide transporter system. After
treatment with IFN-),, part of these class I heavy
chains leave the endoplasmatic reticulum and become
detectable at the cell surface. Reports on immunopre-
cipitation experiments using purified cytotrophoblast
cells show the presence of a 39- and a 45-kD band
(Kovats et al., 1990; Le Bouteiller et al., 1996).
However, the detected proteins seem to be derived
either from contaminations with a cell-island tropho-
blast (which is prominent in preparations of first- and
second-trimester villous cytotrophoblast cells) or is
due to cell-culture conditions.
Extravillous cytotrophoblast (eCT) cells located in
the basal plate, cell islands, chorionic plate, and fetal
membranes share two common features. Those cells
resting on the basal lamina facing the chorionic
mesoderm (chorionic plate, membranes) or the villous
stroma (cell columns, cell islands) seem to be the
proliferating stem cells, whereas the nonproliferating
cells represent more highly differentiated, invasive
daughter cells of the former (Benirschke and Kauf-
mann, 1995). The differences between proliferating
and invasive extravillous cytotrophoblast cells are not
only illustrated by a different distribution of EGFR
and c-erbB2 (Mtihlhauser et al., 1993; Jokhi et al.,
1994), but also by a different distribution of HLA
class I molecules.
Invasive eCT cells in the cell islands, placental
septa, and the basal plate, like interstitial, intramural,
and intraluminal cytotrophoblast cells as well as
trophoblastic giant cells, have been shown to express
HLA-G and additionally, as has been previously
stated, the classical HLA-C molecule (Chumbley et
al., 1994a; King et al., 1996a; Hutter et al., 1996). The
nature of the origin of the trophoblastic giant cells is
controversial. Nevertheless, these cells express HLA-
G and -C antigens. However, Hunt et al. (1991)
reported low amounts of HLA class I mRNA in these
cells compared with other interstitial trophoblast.
In cell columns and cell islands, the expression of
HLA class I molecules is not homogenous. We could
show (Hutter et al., 1996) that cells in the proliferative
zone, proximal to the villous core, do not contain the
HLA-G antigen, but become positive for these
molecules in the distal part of the cell columns as the
cytotrophoblast cells comes into contact with the
uterine wall. Our results confirm findings obtained by
McMaster et al. (1995), who describe the upregula-
tion of HLA-G antigen as an integral part of
cytotrophoblast differentiation along the invasive
pathway. In contrast to HLA-G, the HLA-C antigen
could be detected in the proliferative as well as in the
invasive zone (Hurter et al., 1996). However, Shorter
et al. (1993) reported a complete lack of antigen
staining in the proliferative zone with W6/32. These
results cannot be confirmed by our own observations.
W6/32 and a serum against /32-m did show a less
pronounced signal in the proliferative than in the
invasive zone; nevertheless, there was a clearly
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HLA-B and-C did not show differences in the
staining intensity between the proliferative and inva-
sive zones (Hutter et al., 1996). Our findings are in
agreement with results from Chumbly et al. (1994a),
who detected a cell subpopulation of first-trimester
extravillous cytotrophoblast cells reacting with W6/
32 in fluorescence-activated cell sorter (FACS) analy-
sis, but not with a polyclonal antibody against HLA-
G.
In the fetal membranes, the mRNA for HLA-E and
-G but not for HLA-F can be detected by RNAse
protection analysis (Wei and Orr, 1990). Unfor-
tunately, as the authors worked with the whole tissue
containing trophoblast cells, mesenchymal cells,
decidua cells, and amnionic epithelium cells, the
source of the message cannot be established. In situ
hybridization, carried out by Yelavarthi et al. (1991),
detected the mRNA for HLA-G but not for HLA-E in
extravillous cytotrophoblast cells of term membranes.
However, Houlihan et al. (1995) recently reported the
detection ofHLA-E mRNA and the respective protein
in amnionic epithelial cells. Immunohistochemically
HLA-G was the only HLA class I molecule that could
be detected in extravillous chorionic cytotrophoblast
cells (Shorter et al., 1993; Hutter et al., 1996). In
contrast to these findings, amnionic epithelial cells,
derived from the inner cell mass of the blastocyste,
express all of the classical HLA class I antigens along
with HLA-G and HLA-E (Houlihan et al., 1995;
Hammer et al., 1997).
POSSIBLE FUNCTIONS OF HLA CLASS I
MOLECULES
Although several functions have been proposed both
for HLA-G and HLA-C, their role on trophoblast cells
remains a matter of speculation. Two different types
of immunological functions can be envisaged for
HLA-C and HLA-G. The first is a conventionally
active role in alerting T cells to infection and other
trauma that befall trophoblast cells. Like the classical
HLA class I molecules, HLA-G expressed by trans-
fected LCL.221 cells consists of heavy and light
chains complexed with nonameric endogenous pep-
tides in a 1:1:1 ratio (Lee et al., 1995). Furthermore,
as was shown by a transient cell-cell adhesion assay,
HLA-G is able to bind to a c/c homodimer of the
CD8 receptor that is expressed on T lymphocytes and
some NK cells (Sanders et al., 1991). This enables
HLA-G to act like a classical HLA class I molecule in
presenting peptides to allo-specific T cells. The y/6 T-
cell receptor (TcR) may be the ligand for HLA-G
(Kovats et al., 1991; Houlihan et al., 1992).
The second immunological function is an inhibi-
tory role in preventing the activation of allo-reactive
T and NK cells; the latter preferentially kill target
cells with absent or low levels of HLA class I
molecules. CD56 NK cells infiltrate the decidua at
the onset of pregnancy in large numbers. Ferry et al.
(1991) have shown that extravillous cytotrophoblasts
are resistant to both decidual and peripheral blood NK
cells even after activation of these large granular
lymphocytes (LGL) with interleukin-2. Furthermore,
Chumbley et al. (1994b) showed that HLA-G
LCL.221 transfectants are partially resistant to lysis
by decidual CD56 NK, although this protection was
not as marked as that conferred by HLA-A2. This
finding suggests that HLA-G as well as HLA-C takes
part in the resistance to NK cell attack. An interesting
assumption was made by Loke and King (1991), who
suggested that the CD56 NK cells play a role in the
control of implantation by limiting trophoblast migra-
tion into maternal decidua and spiral arteries with
trophoblast HLA-G as possible regulatory mole-
cules.
The most interesting point--when comparing preg-
nancy with a successful tissue allograft--is how
trophoblast cells, expressing HLA-G and HLA-C,
escape recognition and subsequent destruction by
allo-reactive and HLA-C-specific T cells. HLA-G is
more polymorphic than initially assumed (Van der
Ven and Ober, 1994). Nevertheless, extravillous
cytotrophoblast cells from first-trimester chorionic
tissue were not able to stimulate the proliferation of
purified decidual leukocytes nor of peripheral blood
lymphocytes (King et al., 1996b). Possibly the soluble
forms of HLA-G might play an important role in
suppressing maternal cytotoxic T cells. Soluble HLA-
G molecules derived from transfected LCL.221 cells202 H. HUTTER et al.
show the same motif of bound peptides as the
membrane bound forms on the same cells (Lee et al.,
1995). Therefore, soluble HLA-G could bind either
directly to the TcR or alternatively to CD8 on the T
cell and thereby inhibit the interaction between T cell
and class I antigens on target cells. Furthermore, new
observations from Puppo et al. (1996) report that
phythaemagglutinin-activated CD8 T cells undergo
apoptosis when incubated with purified soluble HLA
class I molecules from human plasma.
Beside the immunological function of the HLA
class I molecules, an involvement in the key functions
of ligand-activated receptors has been suggested. In
mice, structural associations ofHLA class I molecules
with receptors for epidermal growth factor and insulin
(Schreiber et al., 1984; Fehlmann et al., 1985; Due et
al., 1986), as well as for luteinizing hormone
receptors and beta-adrenergic receptors (Solano et al.,
1988), have been reported. A 25-residue peptide
binding to murine MHC-I on the cell surface, not in
the groove but apparently to the cl helix, inhibits
internalization of certain receptors like these for
insulin and glucose, thereby increasing the steady-
state number of active receptors on the cell surface
(Stagsted et al., 1990; Olsson et al., 1994). Further-
more Solano et al. (1988) have suggested that MHC
class I interaction with peptide hormone receptors is
necessary to produce the microaggregation of the
hormone receptor thought to be essential for peptide
hormone action.
CONCLUSION
HLA class I molecules on the maternal-fetal interface
are differentially expressed by trophoblast subpopula-
tions. According to the trophoblast subpopulation and
stage of gestation, a minimal transcription up to rather
high amounts of translated protein can be observed.
Extravillous cytotrophoblast cells are the only tropho-
blast cells expressing membrane-bound HLA class I
molecules associated with/32-m in vivo. Membrane-
bound HLA-G can be detected in extravillous tropho-
blast cells with invasive properties. In contrast to
HLA-G, HLA-C is restricted to extravillous tropho-
blast cells of the basal plate and cell islands, where it
can be found in dividing as well as in invasive cells.
HLA-C cannot be detected in the chorionic extra-
villous trophoblast cells of the fetal membranes. As
soluble HLA-G was found even in syncytiotropho-
blast, further investigations will be necessary to
determine the different functions of soluble and
membrane-bound HLA class I molecules on tropho-
blast cells.
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